NY A10467

Authorizes the New York Superintendent of Insurance to investigate critical prescription drug price increases that exceed the cost of living index over any 12-month period

Defines "critical prescription drug" as medication necessary to prevent or treat conditions where death is possible or imminent

Grants the superintendent subpoena power to compel witness testimony, attendance, and production of relevant books and papers during investigations

Establishes civil penalties for unjustified price increases: up to $5,000 per offense, or two times the aggregate damages or economic gain, whichever is greater

Imposes penalties of up to $1,000 per day for failure to submit required written statements or comply with subpoenas, with refusal to cooperate classified as a misdemeanor